Format
Sort by
Items per page

Send to

Choose Destination

Best matches for thymosin beta 4:

Cardioprotection by Thymosin Beta 4. Pipes GT et al. Vitam Horm. (2016)

Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases. Sosne G et al. Vitam Horm. (2016)

Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. Kim J et al. Vitam Horm. (2016)

Search results

Items: 1 to 20 of 813

1.

Thymosin beta 4-Induced Autophagy Increases Cholinergic Signaling in PrP (106-126)-Treated HT22 Cells.

Han HJ, Kim S, Kwon J.

Neurotox Res. 2018 Dec 15. doi: 10.1007/s12640-018-9985-0. [Epub ahead of print]

PMID:
30552633
2.

Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway.

Zhu L, Ren T, Zhu Z, Cheng M, Mou Q, Mu M, Liu Y, Yao Y, Cheng Y, Zhang B, Cheng Z.

Cell Physiol Biochem. 2018;51(3):1389-1398. doi: 10.1159/000495556. Epub 2018 Nov 27.

3.

Expression and localisation of thymosin beta-4 in the developing human early fetal heart.

Saunders V, Dewing JM, Sanchez-Elsner T, Wilson DI.

PLoS One. 2018 Nov 9;13(11):e0207248. doi: 10.1371/journal.pone.0207248. eCollection 2018.

4.

Angiopoietin-1/Tie2 signaling pathway contributes to the therapeutic effect of thymosin β4 on diabetic peripheral neuropathy.

Wang L, Chopp M, Szalad A, Lu X, Lu M, Zhang T, Zhang ZG.

Neurosci Res. 2018 Oct 13. pii: S0168-0102(18)30441-3. doi: 10.1016/j.neures.2018.10.005. [Epub ahead of print]

PMID:
30326249
5.
6.

Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis.

Carion TW, Ebrahim AS, Kracht D, Agrawal A, Strand E, Kaddurah O, McWhirter CR, Sosne G, Berger EA.

Cells. 2018 Sep 20;7(10). pii: E145. doi: 10.3390/cells7100145.

7.

Thymosin β4 Prevents Oxidative Stress, Inflammation, and Fibrosis in Ethanol- and LPS-Induced Liver Injury in Mice.

Shah R, Reyes-Gordillo K, Cheng Y, Varatharajalu R, Ibrahim J, Lakshman MR.

Oxid Med Cell Longev. 2018 Jul 11;2018:9630175. doi: 10.1155/2018/9630175. eCollection 2018.

8.

Thymosin beta 4 and the eye: the journey from bench to bedside.

Sosne G.

Expert Opin Biol Ther. 2018 Jul;18(sup1):99-104. doi: 10.1080/14712598.2018.1486818.

PMID:
30063853
9.

Thymosin β4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domain.

Shah R, Reyes-Gordillo K, Rojkind M.

Expert Opin Biol Ther. 2018 Jul;18(sup1):177-184. doi: 10.1080/14712598.2018.1478961.

PMID:
30063851
10.

The role of Thymosin β4 in angiotensin II-induced cardiomyocytes growth.

Gupta S, Li L.

Expert Opin Biol Ther. 2018 Jul;18(sup1):105-110. doi: 10.1080/14712598.2018.1494718.

PMID:
30063846
11.

Thymosin β4 promotes endothelial progenitor cell angiogenesis via a vascular endothelial growth factor‑dependent mechanism.

Zhao Y, Song J, Bi X, Gao J, Shen Z, Zhu J, Fu G.

Mol Med Rep. 2018 Aug;18(2):2314-2320. doi: 10.3892/mmr.2018.9199. Epub 2018 Jun 20.

PMID:
29956769
12.

Thymosin beta 4 induces significant changes in the plasma miRNA profile following severe traumatic brain injury in the rat lateral fluid percussion injury model.

Osei J, Kelly W, Toffolo K, Donahue K, Levy B, Bard J, Wang J, Levy E, Nowak N, Poulsen D.

Expert Opin Biol Ther. 2018 Jul;18(sup1):159-164. doi: 10.1080/14712598.2018.1484102.

PMID:
29873258
13.

Crybb2 associates with Tmsb4X and is crucial for dendrite morphogenesis.

Sun M, Ahmad N, Zhang R, Graw J.

Biochem Biophys Res Commun. 2018 Sep 3;503(1):123-130. doi: 10.1016/j.bbrc.2018.05.195. Epub 2018 Jun 6.

PMID:
29864422
14.

No effect of thymosin beta-4 on the expression of the transcription factor Islet-1 in the adult murine heart.

Weinberger F, Nicol P, Starbatty J, Stubbendorff M, Becher PM, Schrepfer S, Eschenhagen T.

Pharmacol Res Perspect. 2018 Jun;6(3):e00407. doi: 10.1002/prp2.407.

15.

Inhibition of acetaminophen-induced hepatotoxicity in mice by exogenous thymosinβ4 treatment.

Wang L, Li X, Chen C.

Int Immunopharmacol. 2018 Aug;61:20-28. doi: 10.1016/j.intimp.2018.05.011. Epub 2018 May 21.

PMID:
29793165
16.

Synthesis and Characterization of Injectable Hydrogels with Varying Collagen⁻Chitosan⁻Thymosin β4 Composition for Myocardial Infarction Therapy.

Shaghiera AD, Widiyanti P, Yusuf H.

J Funct Biomater. 2018 Apr 30;9(2). pii: E33. doi: 10.3390/jfb9020033.

17.

Mechanisms in hypertension and target organ damage: Is the role of the thymus key? (Review).

Dai X, Hua L, Chen Y, Wang J, Li J, Wu F, Zhang Y, Su J, Wu Z, Liang C.

Int J Mol Med. 2018 Jul;42(1):3-12. doi: 10.3892/ijmm.2018.3605. Epub 2018 Mar 30. Review.

18.

A dimeric thymosin beta 4 with novel bio-activity protects post-ischemic cardiac function by accelerating vascular endothelial cell proliferation.

Hao Q, He L, Zhou J, Yuan Y, Ma X, Pang Z, Li W, Zhang Y, Zhang W, Zhang C, Li M.

Int J Cardiol. 2018 Jun 15;261:146-154. doi: 10.1016/j.ijcard.2018.03.052. Epub 2018 Mar 14.

PMID:
29550018
19.

Thymosin beta 4 regulation of actin in sepsis.

Belsky JB, Rivers EP, Filbin MR, Lee PJ, Morris DC.

Expert Opin Biol Ther. 2018 Jul;18(sup1):193-197. doi: 10.1080/14712598.2018.1448381. Epub 2018 Mar 6.

PMID:
29508629
20.

Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations.

Tan WKY, Purnamawati K, Pakkiri LS, Tan SH, Yang X, Chan MY, Drum CL.

Expert Opin Biol Ther. 2018 Jul;18(sup1):141-147. doi: 10.1080/14712598.2018.1448382. Epub 2018 Mar 12.

PMID:
29502471

Supplemental Content

Loading ...
Support Center